Are High-Risk Hypertensive Patients being Prescribed Concomitant Statin Therapy?: A Retrospective Cohort Study

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.5, 2009-10, pp. : 299-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential Impact of NSAIDs on Rate of Adverse Events that Require Hospitalization in High-Risk and General Veteran Populations: A Retrospective Cohort Study

By Pratt Nicole

Drugs & Aging, Vol. 27, Iss. 1, 2010-01 ,pp. : 63-71

Adis International

Access to resources Recommend Favorite

Statin Discontinuation in High-Risk Patients: A Systematic Review of the Evidence

Current Pharmaceutical Design, Vol. 17, Iss. 33, 2011-11 ,pp. : 3669-3689

Bentham Science Publishers

Access to resources Recommend Favorite

Combination of Amlodipine plus Angiotensin Receptor Blocker or Diuretics in High-Risk Hypertensive Patients: A 96-Week Efficacy and Safety Study

By Liyuan

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 2, 2012-04 ,pp. : 137-142

Adis International

Access to resources Recommend Favorite

Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

By Bruckert Eric Hayem Gilles Dejager Sylvie Yau Caroline Bégaud Bernard

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 6, 2005-12 ,pp. : 403-414

Springer Publishing Company

Access to resources Recommend Favorite

Dual antiplatelet therapy: no added benefits for high-risk patients

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite